![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
NBB-001 (boronophenylalanine) is an ionising radiation emitter, which is currently being evaluated for the treatment of recurrent head-and-neck cancer.
Lead Product(s): P-Borono-L-Phenylalanine
Therapeutic Area: Oncology Product Name: NBB-001
Highest Development Status: IND EnablingProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 10, 2024